Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

The infective polymerization of conformationally unstable antithrombin mutants may play a role in the clinical severity of antithrombin deficiency.

Martínez-Martínez I, Navarro-Fernández J, Aguila S, Miñano A, Bohdan N, De La Morena-Barrio ME, Ordóñez A, Martínez C, Vicente V, Corral J.

Mol Med. 2012 Jul 18;18:762-70. doi: 10.2119/molmed.2012.00017.

2.

Antithrombin Murcia (K241E) causing antithrombin deficiency: a possible role for altered glycosylation.

Martínez-Martínez I, Ordóñez A, Navarro-Fernández J, Pérez-Lara A, Gutiérrez-Gallego R, Giraldo R, Martínez C, Llop E, Vicente V, Corral J.

Haematologica. 2010 Aug;95(8):1358-65. doi: 10.3324/haematol.2009.015487. Epub 2010 Apr 30.

3.

Amelioration of the severity of heparin-binding antithrombin mutations by posttranslational mosaicism.

Martínez-Martínez I, Navarro-Fernández J, Østergaard A, Gutiérrez-Gallego R, Padilla J, Bohdan N, Miñano A, Pascual C, Martínez C, de la Morena-Barrio ME, Aguila S, Pedersen S, Kristensen SR, Vicente V, Corral J.

Blood. 2012 Jul 26;120(4):900-4. doi: 10.1182/blood-2012-01-406207. Epub 2012 Apr 12.

4.

Mutations in the shutter region of antithrombin result in formation of disulfide-linked dimers and severe venous thrombosis.

Corral J, Huntington JA, González-Conejero R, Mushunje A, Navarro M, Marco P, Vicente V, Carrell RW.

J Thromb Haemost. 2004 Jun;2(6):931-9.

5.

Characterization of molecular defect of 13387-9delG mutated antithrombin in inherited type I antithrombin deficiency.

Wang WB, Fu QH, Ding QL, Zhou RF, Wu WM, Hu YQ, Wang XF, Yan LX, Wang ZY, Wang HL.

Blood Coagul Fibrinolysis. 2005 Mar;16(2):149-55.

PMID:
15741804
6.

Hyperglycaemia impairs antithrombin secretion: possible contribution to the thrombotic risk of diabetes.

Hernández-Espinosa D, Ordóñez A, Miñano A, Martínez-Martínez I, Vicente V, Corral J.

Thromb Res. 2009 Sep;124(4):483-9. doi: 10.1016/j.thromres.2009.05.020. Epub 2009 Jul 2.

PMID:
19573895
7.

Characterization of the conformational alterations, reduced anticoagulant activity, and enhanced antiangiogenic activity of prelatent antithrombin.

Richard B, Swanson R, Schedin-Weiss S, Ramirez B, Izaguirre G, Gettins PG, Olson ST.

J Biol Chem. 2008 May 23;283(21):14417-29. doi: 10.1074/jbc.M710327200. Epub 2008 Mar 28.

8.

Effect of citrullination on the function and conformation of antithrombin.

Ordóñez A, Martínez-Martínez I, Corrales FJ, Miqueo C, Miñano A, Vicente V, Corral J.

FEBS J. 2009 Nov;276(22):6763-72. doi: 10.1111/j.1742-4658.2009.07391.x. Epub 2009 Oct 16.

9.

Antithrombins Wibble and Wobble (T85M/K): archetypal conformational diseases with in vivo latent-transition, thrombosis, and heparin activation.

Beauchamp NJ, Pike RN, Daly M, Butler L, Makris M, Dafforn TR, Zhou A, Fitton HL, Preston FE, Peake IR, Carrell RW.

Blood. 1998 Oct 15;92(8):2696-706.

10.

Refolding and polymerization pathways of neuroserpin.

Takehara S, Zhang J, Yang X, Takahashi N, Mikami B, Onda M.

J Mol Biol. 2010 Nov 12;403(5):751-62. doi: 10.1016/j.jmb.2010.07.047. Epub 2010 Aug 4.

PMID:
20691191
11.

Detection of conformational transformation of antithrombin in blood with crossed immunoelectrophoresis: new application for a classical method.

Corral J, Rivera J, Martínez C, González-Conejero R, Miñano A, Vicente V.

J Lab Clin Med. 2003 Nov;142(5):298-305.

PMID:
14647033
12.

L-asparaginase-induced antithrombin type I deficiency: implications for conformational diseases.

Hernández-Espinosa D, Miñano A, Martínez C, Pérez-Ceballos E, Heras I, Fuster JL, Vicente V, Corral J.

Am J Pathol. 2006 Jul;169(1):142-53.

13.

In vivo effects of hyperthermia on the functional and conformational characteristics of antithrombin.

Hernández-Espinosa D, Mota R, Miñano A, Ordóñez A, Yélamos J, Vicente V, Corral J.

J Thromb Haemost. 2007 May;5(5):963-70.

14.

Enhancement of heparin cofactor II anticoagulant activity.

Bauman SJ, Church FC.

J Biol Chem. 1999 Dec 3;274(49):34556-65.

15.

Antithrombin Dublin (p.Val30Glu): a relatively common variant with moderate thrombosis risk of causing transient antithrombin deficiency.

Navarro-Fernández J, de la Morena-Barrio ME, Padilla J, Miñano A, Bohdan N, Águila S, Martínez-Martínez I, Sevivas TS, de Cos C, Fernández-Mosteirín N, Llamas P, Asenjo S, Medina P, Souto JC, Overvad K, Kristensen SR, Corral J, Vicente V.

Thromb Haemost. 2016 Jul 4;116(1):146-54. doi: 10.1160/TH15-11-0871. Epub 2016 Apr 21.

PMID:
27098529
16.

Antithrombin Phe229Leu: a new homozygous variant leading to spontaneous antithrombin polymerization in vivo associated with severe childhood thrombosis.

Picard V, Dautzenberg MD, Villoutreix BO, Orliaguet G, Alhenc-Gelas M, Aiach M.

Blood. 2003 Aug 1;102(3):919-25. Epub 2003 Feb 20.

17.

Disease-causing mutations in the CLRN1 gene alter normal CLRN1 protein trafficking to the plasma membrane.

Isosomppi J, Västinsalo H, Geller SF, Heon E, Flannery JG, Sankila EM.

Mol Vis. 2009 Sep 8;15:1806-18.

18.

Antithrombin and its deficiency states.

Lane DA, Olds RR, Thein SL.

Blood Coagul Fibrinolysis. 1992 Jun;3(3):315-41. Review.

PMID:
1643210
19.

[Molecular mechanisms of antithrombin deficiency caused by T98I and A404T mutation].

Zhou RF, Dai J, Fu QH, Wang WB, Xie S, Ding QL, Wang XF, Wang HL.

Zhonghua Yi Xue Za Zhi. 2007 Apr 10;87(14):987-90. Chinese.

PMID:
17650426
20.

The phenotypic and genetic assessment of antithrombin deficiency.

Cooper PC, Coath F, Daly ME, Makris M.

Int J Lab Hematol. 2011 Jun;33(3):227-37. doi: 10.1111/j.1751-553X.2011.01307.x. Epub 2011 Mar 15. Review.

PMID:
21401902

Supplemental Content

Support Center